March 23, 2010 – Frost and Sullivan gave a 2010 North American New Product Innovation Award to Positron Corp. for its pioneering cardiac positron emission tomography (PET) scanner, the Attrius.
The nuclear scanner was developed for molecular imaging of the heart. Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
“This is the most exciting time in the history of the Positron Corporation,” said Joseph Oliverio, CTO of Positron. “The emergence of cardiac PET, as the preferred nuclear cardiology imaging modality in light of the recent SPECT reimbursement reductions and radiopharmaceutical shortages, position Positron as the only company offering a new scanner solution for the current unprecedented market demand.”
Positron was founded in 1983 and is focused on nuclear cardiology. It offers a proprietary product line that includes imaging systems and radiopharmaceutical distribution.
For more information: www.positron.com
October 19, 2026 
